Intuitive wins FDA clearances for cardiac procedures on da Vinci 5

Intuitive Surgical (Nasdaq: ISRG)+ has received FDA clearance for “several cardiac procedures,” CEO Dave Rosa said today while announcing the surgical robotics company’s latest financial and operating results.

Those clearances cover Intuitive’s latest-generation da Vinci 5 (DV5) using non-Force Feedback instruments, he said. Intuitive did not name the specific procedures, and they do not appear to be publicly available in the FDA’s 510(k) clearance database.

“Given the complexity of minimally invasive cardiac surgery, we are planning a measured roll-out to support training, education and adoption,” Rosa said. “We believe deeply that patients requiring cardiac surgery can benefit from a minimally invasive approach with da Vinci and look forward to actively supporting our customers through these procedures.”

Sign up for Blog Updates